Four pharmaceutical companies – AmerisourceBergen, Cardinal Health, and McKesson— along with Johnson & Johnson are facing a $26 billion settlement with U.S. states and attorney generals over their responsibility in the opioid crisis. While not officially unveiled, the settlement is expected to have J&J pay $5 billion over the next nine years while the other three pay $21 billion over 18 years.